| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.9M | -44.9% |
| Cost of Revenue | $17.4M | -47.6% |
| Gross Profit | $5.5M | -34.0% |
| R&D Expense | $1.1M | +18.6% |
| SG&A Expense | $9.7M | -4.0% |
| Operating Income | -$5.2M | -97.7% |
| Pre-tax Income | -$4.8M | -151.2% |
| Income Tax | -$1.4M | — |
| Net Income | $31.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.6M | +1062.0% |
| Accounts Receivable | $7.8M | -13.1% |
| Inventory | $6.1M | -19.9% |
| Current Assets | $56.7M | +104.7% |
| Total Assets | $66.0M | +99.7% |
| Current Liabilities | $30.0M | +64.2% |
| Total Liabilities | $30.5M | +62.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.2M | -59.5% |
| Capital Expenditures | $3.8M | +50.6% |
| Investing Cash Flow | $38.9M | +1657.5% |
| Financing Cash Flow | $5.4M | +1764.4% |
| Free Cash Flow | -$10.0M | -56.0% |
| +1778.3% |
| EPS (Basic) | $2.97 | +1663.2% |
| EPS (Diluted) | $2.90 | +1626.3% |
| Stockholders' Equity |
| $35.4M |
| +149.2% |